This study was supported by the China Mega-Project for Infectious Diseases(Grant Nos.2017ZX10203202 and 2013ZX10002005);the China Mega-Project for Innovative Drugs(Grant No.2016ZX09101065).
Background and Aims:Chronic hepatitis B is the main cause of liver cancer.However,the most neglected group has been treatment-naive chronic hepatitis B patients with normal alanine aminotransferase(ALT).People have te...
Ascletis Pharmaceuticals Co.,Ltd.provided financial support for this study(MANASA)
Background and Aims:Genotype(GT)1 remains the predominant hepatitis c virus(HCV)GT in Chinese patients.Over 80%of those Chinese patients harbor the interferon-sensitive CC allele of IFNL4rs12979860,which is favorable ...
Ascletis BioScience Co.,Ltd.provided financial support for this study
Background and Aims:Ravidasvir(RDV)is a new generation pangenotypic hepatitis C virus(HCV)NS5A inhibitor,with high barrier to baseline resistance-associated species.This is the first phase 2/3 study conducted in China...
Financial support for this study was provided by the Faculty of Medicine at Al-Azhar University,National Research Center;by the Academy of Scientific Research and Technology Development Fund(Grant No.3365,to Mostafa K El-Awady).A grant from Alexion Corp.and the Herman Lopata Chair in Hepatitis Research is gratefully acknowledged
Background and Aims:Occult HCV infections(OCIs)include IgG antibody seronegative cryptogenic(COCIs),as well as seropositive secondary na(i)ve(SNOCIs)and experienced(SEOCIs)cases.We used peripheral-blood-mononuclear-ce...
Financial support for this study was provided by the Faculty of Medicine at Al-Azhar University,National Research Center;by the Academy of Scientific Research and Technology Development Fund(Grant 3365,to Mostafa K El Awady)
Background and Aims:Hepatitis C virus(HCV)hepatotropism is associated with intra-peripheral blood mononuclear cell(PBMC)infection that causes post-treatment relapse in RNA seronegative patients.Our understanding of th...